CapitolRadar tracks every publicly disclosed ANGO trade by US congress members and corporate insiders: 7 disclosed trades (2 buys, 5 sells) by 1 tracked traders, from 2025-06-26 to 2025-10-20. Updated daily from official filings.
Want a ping when Congress buys ANGO? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
AngioDynamics, Inc. (ANGO) — Healthcare · Medical - Instruments & Supplies, market cap about $0.5B.
CapitolRadar analysis
7 disclosures, concentrated in one trader
7 tracked ANGO trades were disclosed from June 26, 2025, through October 20, 2025: 2 buys and 5 sells. The dataset includes only 1 distinct trader, making the record highly concentrated rather than a broad signal across multiple filers. Debbie Wasserman Schultz is identified as the buyer in both purchases, with her latest buy dated June 27, 2025.
The sample is small: seven trades by one person over less than four months. That limits conclusions about whether the pattern reflects wider congressional or insider sentiment toward AngioDynamics, a Healthcare company in the Medical - Instruments & Supplies industry.
2 Q2 buys preceded 5 Q3–Q4 sells
2 trades occurred in 2025 Q2, both buys. The balance shifted afterward. The 2 trades reported for 2025 Q3 were both sells, because that quarter recorded zero buys. In 2025 Q4, all 3 tracked trades were also sells. Across the reported quarterly sequence, buying was confined to Q2, while selling accounted for every tracked transaction in Q3 and Q4.
This creates a clear directional sequence within the available data: 2 buys first, followed by 5 sells. However, the facts provided do not include transaction values, exact share counts, prices, ownership changes, or reasons for the trades, so the size and economic significance of that sequence cannot be measured here.
Disclosure timing and value caveats
Up to 45 days may separate a trade from its public disclosure. As a result, filing visibility can lag the underlying transaction and should not be treated as real-time activity. Transaction amount ranges, when reported, are estimates rather than exact values; no amount ranges are provided in this dataset. Combined with the one-trader, seven-trade sample, these limitations make the record descriptive but narrow.
Analysis written from the tracked record on 2026-09-21; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2025 Q4 | 3 | 0 | 3 |
| 2025 Q3 | 2 | 0 | 2 |
| 2025 Q2 | 2 | 2 | 0 |
Who is buying ANGO?
| Trader | Disclosed buys | Last buy | Grade |
|---|---|---|---|
| Debbie Wasserman Schultz | 2 | 2025-06-27 | — |
Disclosed trades in ANGO
| Date | Who | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2025-10-20 | Debbie Wasserman Schultz | sell | $1,001 - $15,000 | — |
| 2025-10-20 | Debbie Wasserman Schultz | sell | $100,001 - $250,000 | — |
| 2025-10-19 | Debbie Wasserman Schultz | sell | $100,001 - $250,000 | — |
| 2025-07-16 | Debbie Wasserman Schultz | sell | $1,001 - $15,000 | — |
| 2025-07-15 | Debbie Wasserman Schultz | sell | $1,001 - $15,000 | — |
| 2025-06-27 | Debbie Wasserman Schultz | buy | $1,001 - $15,000 | — |
| 2025-06-26 | Debbie Wasserman Schultz | buy | $1,001 - $15,000 | — |
About AngioDynamics, Inc.
AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The company's portfolio includes advanced ablation systems like NanoKnife, designed for the precise surgical removal of soft tissues, and Solero microwave and radiofrequency systems, effective …
Frequently asked questions
Which politicians bought ANGO most?
Debbie Wasserman Schultz leads with 2 disclosed buys.
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.